Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

BMS scores first oesophageal cancer nod for Opdivo in Japan

BMS scores first oesophageal cancer nod for Opdivo in Japan Opdivo met the primary endpoint of overall survival (OS), demonstrating a 23% reduction in the risk of death and a 2.5 month improvement in OS when compared to chemotherapy. ... The survival benefit with Opdivo treatment was observed regardless of tumour

BMS’ Opdivo combo misses the mark in pancreatic cancer

BMS’ Opdivo combo misses the mark in pancreatic cancer Patients were randomised to receive the Opdivo/cabiralizumab combination, chemotherapy alone, or the Opdivo/cabiralizumab with one of two different chemotherapy regimens. ... The blow is more significant for Five Prime than it is for BMS – the

FDA sets June decision date for Tecentriq monotherapy in NSCLC

FDA sets June decision date for Tecentriq monotherapy in NSCLC Bristol-Myers Squibb’s own PD-1 inhibitor Opdivo(nivolumab) is currently under review with the FDA, in combination with low-dose CTLA4 inhibitor Yervoy (ipilimumab) in previously-untreated NSCLC patients

BMS unveils long-term results for Opdivo in kidney cancer

BMS unveils long-term results for Opdivo in kidney cancer Results include updated data for Opdivo with or without Yervoy. Bristol-Myers Squibb has unveiled long-term results for Opdivo in renal cell carcinoma, which demonstrated efficacy with and without CTLA4 ... BMS also reported updated results from its

20 for 2020 – Five pharma companies to watch

20 for 2020 – Five pharma companies to watch The merger was completed shortly after BMS reported the first decline in quarterly sales of its immuno-oncology blockbuster Opdivo (nivolumab) since its launch five years ago, and 2020 is viewed ... Opdivo is being squeezed out of the market by Merck &Co/

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics